Investment Counselors of Maryland’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-348,225
Closed -$12.2M 204
2016
Q1
$12.2M Sell
348,225
-113,300
-25% -$3.66M 0.7% 85
2015
Q4
$14.9M Buy
461,525
+2,800
+0.6% +$90.8K 0.86% 53
2015
Q3
$14.8M Sell
458,725
-46,650
-9% -$1.76M 0.87% 50
2015
Q2
$20.9M Hold
505,375
0.97% 32
2015
Q1
$22.7M Buy
505,375
+275
+0.1% +$11.5K 1.07% 24
2014
Q4
$18.9M Hold
505,100
0.92% 50
2014
Q3
$17.6M Buy
505,100
+47,783
+10% +$1.71M 0.88% 56
2014
Q2
$16.1M Buy
+457,317
New +$15.3M 0.7% 83

Other funds holding HAE

Investment Counselors of Maryland's HAE Position: Q2 2016 in Review

Investment Counselors of Maryland sold out of Haemonetics (HAE) in Q2 2016, closing a stake of 348,225 shares — an estimated $12.2M sold.

Investment Counselors of Maryland first reported a position in HAE in Q2 2014 and held it in 8 quarters. The position peaked at $22.7M in Q1 2015. 178 funds tracked by Wall St. Rank hold HAE as of Q2 2016.

  • Investment Counselors of Maryland reported no remaining Haemonetics position as of Q2 2016 after selling out during the quarter.
  • Investment Counselors of Maryland sold 348,225 Haemonetics shares in Q2 2016, an estimated $12.2M.
  • Investment Counselors of Maryland first reported a position in Haemonetics in Q2 2014 and held it in 8 quarters.
  • Investment Counselors of Maryland's Haemonetics position peaked at $22.7M in Q1 2015.
  • 178 funds tracked by Wall St. Rank held Haemonetics as of Q2 2016.

Based on Investment Counselors of Maryland's 13F filing for Q2 2016, filed 9 Aug 2016.